Andrew Short v. HHS - Influenza, Guillain-Barré syndrome (GBS) (2023)

Andrew Short filed a petition for compensation under the National Vaccine Injury Compensation Program on February 8, 2022, alleging that he suffered Guillain-Barré syndrome (GBS) as a result of an influenza vaccine administered on October 28, 2019. The respondent filed a Rule 4(c) report conceding that Mr.

Short was entitled to compensation, as his condition met the criteria set forth in the Vaccine Injury Table for GBS with onset between three and forty-two days after vaccination and no apparent alternative cause. A ruling on entitlement was issued on November 7, 2022, finding Mr.

Short entitled to compensation. Subsequently, on January 31, 2023, the respondent filed a proffer on award of compensation, proposing a total award of $121,454.31, consisting of $120,000.00 for pain and suffering and $1,454.31 for documented out-of-pocket expenses.

Mr. Short agreed with this proffered award.

The Chief Special Master issued a decision awarding Mr. Short the lump sum of $121,454.31 on March 3, 2023.